ACROInsights
LinkedInnewsletter · by ACROBiosystems
Latest news and insights from ACROBiosystems Group.
- Audience
- Not shown publicly
- We show a dash rather than guess
- Publishing
- Every two weeks
- 5 posts indexed in the last 90 days
- Last post
- Oct 14, 2026
- 16 days ago
- Likely audience
- Drug discovery scientists
- Inferred from post content
ACROInsights is a LinkedIn newsletter by ACROBiosystems covering Cardiac safety assessment, Drug development and Cardiac organoids. NewsletterFIT indexed 5 posts from it in the last 90 days, most recently on Oct 14, 2026.
Topics
- Cardiac safety assessment
- Drug development
- Cardiac organoids
- Human-induced pluripotent stem cells
- hERG screening
Recent posts
- From Human‑Relevant…
- New Product…
- Application Oriented…
- Application‑Oriented Functional…
- CD19 as…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on ACROInsights
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
Similar newsletters
Ranked by how many topics they share with ACROInsights.
- The Clinical Trials Abundance blog1K subscribers
SubstackMonthly or less · last post 50 days ago
Likely audience: healthcare policymakers
1 shared topic
- The Codon1K subscribers
SubstackMonthly or less · last post 32 days ago
Likely audience: Geneticists
1 shared topic
LinkedInMonthly or less · last post 13 days ago
Likely audience: Biotechnology students
1 shared topic
Compiled from public pages · refreshed Oct 31, 2026 · How NewsletterFIT collects and labels data